Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marcello Viscovo
Observed names:
M V Viscovo,
M Viscovo,
M. Viscovo,
Viscovo, Marcello
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico,
IRCCS Humanitas Research Hospital
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico,
IRCCS Humanitas Research Hospital,
University of Naples Federico II
ORCID:
0000-0003-3012-6539
Observed ORCID:
0000-0003-3012-6539
OpenAlex ID:
A5086824739
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas
2024
·
Francesco D’Alò
, Silvia Bellesi
, et al.
·
Cancers
·
30
Sodium–glucose cotransporter 2 inhibitors and the cancer patient: from diabetes to cardioprotection and beyond
2024
·
Massimiliano Camilli
, Marcello Viscovo
, et al.
·
Basic Research in Cardiology
·
22
PDF
Cytomorphology of normal, reactive, dysmorphic, and dysplastic megakaryocytes in bone marrow aspirates
2021
·
Gina Zini
, Marcello Viscovo
·
International Journal of Laboratory Hematology
·
20
PDF
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study
2024
·
Massimiliano Camilli
, Marcello Viscovo
, et al.
·
Cardio-Oncology
·
16
PDF
Predicting therapy‐related myeloid neoplasms after CAR‐T with the Clonal Haematopoiesis Risk Score (CHRS)
2024
·
Eugenio Galli
, Monica Rossi
, et al.
·
British Journal of Haematology
·
12
PDF
Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR)
2024
·
Eugenio Galli
, Marcello Viscovo
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
Cardio-oncology: Emerging Concepts in Cardiovascular Sequelae of Cancer Therapies, Translational Research and Reverse Cardio-oncology
2025
·
Massimiliano Camilli
, Luca Maggio
, et al.
·
European Cardiology Review
·
10
Baseline Tumor Burden Assessed With AI‐Guided PET/CT Total Metabolic Tumor Volume (TMTV) and LDH Levels Predict Efficacy of CAR‐T in Aggressive B‐Cell Lymphoma
2024
·
Eugenio Galli
, Andrea Guarneri
, et al.
·
Hematological Oncology
·
10
PDF
Digital morphology compared to the optical microscope: A validation study on reporting bone marrow aspirates
2024
·
G. Zini
, P. Chiusolo
, et al.
·
International Journal of Laboratory Hematology
·
9
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
2021
·
Eugenio Galli
, Silvia Bellesi
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
·
8
PDF
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation
2020
·
Federica Sorà
, Patrizia Chiusolo
, et al.
·
Transfusion and Apheresis Science
·
8
PDF
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma
2022
·
Annarosa Cuccaro
, Silvia Bellesi
, et al.
·
Journal of Leukocyte Biology
·
7
PDF
Strain-derived myocardial work indices in adult cancer survivors: results from an observational study and comparison with available reference ranges
2025
·
Massimiliano Camilli
, Federico Ballacci
, et al.
·
Cardio-Oncology
·
6
PDF
Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study
2025
·
Eugenio Galli
, Roberta Di Blasi
, et al.
·
Blood Advances
·
6
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry
2024
·
Silvia Bellesi
, Gabriele Schiaffini
, et al.
·
Cytometry Part B Clinical Cytometry
·
6
PDF
Incessant Pericarditis Successfully Treated With Anakinra in a Patient on Active Treatment for Mediastinal Lymphoma
2022
·
Massimiliano Camilli
, Marcello Viscovo
, et al.
·
Canadian Journal of Cardiology
·
6
Vascular inflammation in patients undergoing anti-CD19 chimeric antigen receptor-T cells for haematologic malignancies: a call for cardiovascular surveillance
2025
·
Massimiliano Camilli
, Andrea Guarneri
, et al.
·
European Heart Journal
·
5
PDF
Frail is not fail: Limited impact of comorbidities on non‐relapse mortality and safety in patients with LBCL treated with CAR ‐T
2025
·
Eugenio Galli
, Roberta Di Blasi
, et al.
·
British Journal of Haematology
·
5
PDF
Heterogeneous Surface CD79b Expression in Aggressive B-Cell Lymphomas Assessed by Flow Cytometry on Lymph Node Biopsies
2024
·
Elena Maiolo
, Silvia Bellesi
, et al.
·
Cancers
·
5
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment
2022
·
Silvia Bellesi
, Michela Sali
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
3
InflaMix Predicts Severe CRS , ICU Admission, and Progression‐Free Survival After CAR ‐T Therapy in LBCL
2026
·
Eugenio Galli
, Daniele Mannina
, et al.
·
European Journal Of Haematology
·
2
PDF
Late HBV reactivation after hematopoietic stem cell transplantation, despite long-term prophylaxis
2023
·
Marcello Viscovo
, Elisabetta Metafuni
, et al.
·
European Journal of Clinical Microbiology & Infectious Diseases
·
2
Multicolor flow cytometry on pericardial effusion for a prompt diagnosis and treatment of hematological malignancies with heart involvement
2022
·
Luigi Cappannoli
, Massimo Imazio
, et al.
·
Frontiers in Cardiovascular Medicine
·
2
Tracking Inflammation in CAR-T Therapy: The Emerging Role of Serum Amyloid A (SAA)
2025
·
Ilaria Pansini
, Eugenio Galli
, et al.
·
Cancers
·
1
PDF
Treatment outcomes in elderly patients ≥ 65 years with Large B-Cell Lymphoma (LBCL): a real-world single center experience focusing on potential CD19-CAR-T eligibility in second line
2025
·
Elena Maiolo
, Gabriele Schiaffini
, et al.
·
Annals of Hematology
·
1
PDF
Show more works
View as search
Works count:
43
Citation count:
215
H-index:
9
I10-index:
8
Year
Topic
Type